IPO activity rebounded in the second half of the year, with the technology and healthcare sectors maintaining their dominance in public listings.
IPO News: What to look for when Lumexa Imaging goes public
Categories
Diagnostics
Earnings Summary: Agilent (A) reports higher Q3 2025 revenue and profit
Healthcare company Agilent Technologies Inc. (NYSE: A) has reported higher revenue and adjusted earnings for the third quarter of fiscal 2025. The
Earnings Summary: Revvity (RVTY) reports higher revenue and earnings for Q1 2025
Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenue and adjusted profit
Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance
Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided cautious first-quarter
Earnings Summary: Highlights of Baxter International’s Q4 2024 report
Baxter International Inc. (NYSE: BAX) on Thursday announced financial results for the fourth quarter of 2024. The medical device maker's sales increased
Agilent Technologies (A) Earnings: 4Q23 Key Numbers
Agilent Technologies Inc. (NYSE: A) reported revenue of $1.69 billion for the fourth quarter of 2023, down 8.7% on a reported basis
Key highlights from Thermo Fisher’s (TMO) Q3 2023 earnings results
Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2023 earnings results today. Revenue dropped 1% year-over-year to $10.57 billion. Organic revenues
IQVIA Holdings Inc (IQV) Q1 2023 Earnings Call Transcript
IQVIA Holdings Inc (NYSE: IQV) Q1 2023 Earnings Conference Call dated Apr. 27, 2023 Corporate Participants: Nick Childs -- Senior Vice President,
Thermo Fisher (TMO) stock can add value to your portfolio. Here’s why
For Thermo Fisher Scientific Inc. (NYSE: TMO), a leading player in the medical diagnostics and life sciences market, 2020 was a busy
Quest Diagnostics Inc (DGX) Q1 2021 Earnings Call Transcript
Quest Diagnostics Inc (NYSE: DGX) Q1 2021 earnings call ended Apr. 22, 2021 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen
Centogene N.V. (CNTG) Q2 2020 Earnings Call Transcript
Centogene N.V. (NASDAQ: CNTG) Q2 2020 earnings call dated Sep. 23, 2020 Corporate Participants: Sun Kim -- Chief Strategy and Investor Relations Officer Prof.
Agilent Technologies Inc. (A) Q3 2020 Earnings Call Transcript
Agilent Technologies Inc (NYSE: A) Q3 2020 earnings call dated Aug. 18, 2020 Corporate Participants: Ankur Dhingra -- Vice President of Investor Relations Mike
Biocept Inc. (BIOC) Q2 2020 Earnings Call Transcript
Biocept Inc. (NASDAQ: BIOC) Q2 2020 earnings call dated Aug. 12, 2020 Corporate Participants: Jody Cain -- Investor Relations Michael W. Nall -- President and Chief
Biocept (BIOC) revenue drops 23% in Q2; loss narrows
Biocept (NASDAQ: BIOC) reported a narrower loss in the second quarter of 2020. The company's revenue declined by 23% year-over-year to $917,000,
Quest Diagnostics Inc (DGX) Q2 2020 Earnings Call Transcript
Quest Diagnostics Inc (NYSE: DGX) Q2 2020 earnings call dated July 23, 2020 Corporate Participants: Shawn Bevec -- Vice President, Investor Relations Stephen H.
Centogene N.V. (NASDAQ: CNTG) Q1 2020 Earnings Call Transcript
Centogene N.V. (CNTG) Q1 2020 earnings call dated June 15, 2020 Corporate Participants: Sun Kim -- Chief Strategy & Investor Relations Officer, Chief Business
Biocept Inc. (NASDAQ: BIOC) Q1 2020 Earnings Call Transcript
Biocept Inc. (BIOC) Q1 2020 earnings call dated May 13, 2020 Corporate Participants: Jody Cain -- Investor Relations Michael W. Nall -- President and Chief Executive